A comparative study of frusemide-amiloride and cyclopenthiazide-potassium chloride in the treatment of congestive cardiac failure in general practice. 1988

R J Crawford, and S Allman, and W Gibson, and S Kitchen, and H H Richards
Rorer Health Care Ltd, St Leonards House, Eastbourne, UK.

Forty-seven patients entered this comparison of frusemide-amiloride and cyclopenthiazide-potassium chloride in the treatment of congestive cardiac failure in general practice. Frusemide-amiloride was 'very satisfactory' in 92% of the patients compared to only 55% who took cyclopenthiazide-potassium chloride. Significantly more patients were free of paroxysmal nocturnal dyspnoea and orthopnoea after taking frusemide-amiloride.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D011189 Potassium Chloride A white crystal or crystalline powder used in BUFFERS; FERTILIZERS; and EXPLOSIVES. It can be used to replenish ELECTROLYTES and restore WATER-ELECTROLYTE BALANCE in treating HYPOKALEMIA. Slow-K,Chloride, Potassium
D003518 Cyclopenthiazide Thiazide diuretic also used as an antihypertensive agent. Cyclomethiazide
D004232 Diuretics Agents that promote the excretion of urine through their effects on kidney function. Diuretic,Diuretic Effect,Diuretic Effects,Effect, Diuretic,Effects, Diuretic
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004417 Dyspnea Difficult or labored breathing. Orthopnea,Platypnea,Recumbent Dyspnea,Rest Dyspnea,Trepopnea,Breathlessness,Shortness of Breath,Breath Shortness,Dyspnea, Recumbent,Dyspnea, Rest,Dyspneas, Rest
D004487 Edema Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE. Dropsy,Hydrops,Anasarca

Related Publications

R J Crawford, and S Allman, and W Gibson, and S Kitchen, and H H Richards
January 1990, The Journal of international medical research,
R J Crawford, and S Allman, and W Gibson, and S Kitchen, and H H Richards
January 1984, Current medical research and opinion,
R J Crawford, and S Allman, and W Gibson, and S Kitchen, and H H Richards
August 1973, Current therapeutic research, clinical and experimental,
R J Crawford, and S Allman, and W Gibson, and S Kitchen, and H H Richards
December 1949, Southern medical journal,
R J Crawford, and S Allman, and W Gibson, and S Kitchen, and H H Richards
December 1962, Svenska lakartidningen,
R J Crawford, and S Allman, and W Gibson, and S Kitchen, and H H Richards
November 1996, Journal of the American College of Cardiology,
R J Crawford, and S Allman, and W Gibson, and S Kitchen, and H H Richards
October 1984, Clinical pharmacology and therapeutics,
R J Crawford, and S Allman, and W Gibson, and S Kitchen, and H H Richards
June 1981, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
R J Crawford, and S Allman, and W Gibson, and S Kitchen, and H H Richards
November 2010, The Medical journal of Australia,
Copied contents to your clipboard!